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HCFC1 is a common component of active human
CpG-island promoters and coincides with ZNF143,
THAP11, YY1, and GABP transcription
factor occupancy
Joe¨lle Michaud,1,3 Viviane Praz,1 Nicole James Faresse,1 Courtney K. JnBaptiste,1,4
Shweta Tyagi,1,5 Fre´de´ric Schu¨tz,2 and Winship Herr1,6
1Center for Integrative Genomics, University of Lausanne, Ge´nopode, 1015 Lausanne, Switzerland; 2Bioinformatics Core Facility,
SIB Swiss Institute of Bioinformatics, Ge´nopode, 1015 Lausanne, Switzerland
In human transcriptional regulation, DNA-sequence-specific factors can associate with intermediaries that orchestrate
interactions with a diverse set of chromatin-modifying enzymes. One such intermediary is HCFC1 (also known as HCF-1).
HCFC1, first identified in herpes simplex virus transcription, has a poorly defined role in cellular transcriptional regu-
lation. We show here that, in HeLa cells, HCFC1 is observed bound to 5400 generally active CpG-island promoters.
Examination of the DNA sequences underlying the HCFC1-binding sites revealed three sequence motifs associated with the
binding of (1) ZNF143 and THAP11 (also known as Ronin), (2) GABP, and (3) YY1 sequence-specific transcription factors.
Subsequent analysis revealed colocalization of HCFC1 with these four transcription factors at ~90% of the 5400 HCFC1-
bound promoters. These studies suggest that a relatively small number of transcription factors play a major role in HeLa-
cell transcriptional regulation in association with HCFC1.
[Supplemental material is available for this article.]
In eukaryotes, DNA-sequence-specific transcription factors and
chromatin-modifying activities work together to regulate the
initiation of transcription at promoters by core-promoter-bind-
ing factors and RNA polymerases. There exists also a more limited
class of transcriptional regulators whose members coordinate the
interaction of the DNA-binding transcription factors and chro-
matin-modifying activities. One of these factors is the host-cell
factor HCFC1 (also known as HCF-1), which was discovered in
studies of herpes simplex virus (HSV) transcription (for reviews,
see Wysocka and Herr 2003; Kristie et al. 2010) and for which
a mechanistic understanding of its cellular role has remained rela-
tively enigmatic, largely because it does not display DNA-binding
activity.
HCFC1 is synthesized as a 2035-amino-acid precursor that is
cleaved by O-GlcNAc transferase (OGT) to generate a heterodimeric
complex of amino-terminal HCFC1N and carboxy-terminal HCFC1C
subunits (Capotosti et al. 2011) that regulate different aspects of the
cell-division cycle ( Julien and Herr 2003).
Although HCFC1 does not display direct DNA-binding activ-
ity, it associates with chromatin via a Kelch-repeat domain within
the HCFC1N subunit (Wysocka et al. 2001). The Kelch-repeat do-
main is predicted to formab-propeller structure that binds to a short
sequence motif, D/EHxY, called the HCFC1-binding motif (HBM)
(Freiman and Herr 1997; Lu et al. 1998), which is found in several
HCFC1-associated DNA-binding transcription factors (for review,
see Zargar and Tyagi 2012). HCFC1 likewise associates with a
constellation of chromatin-modifying activities. These latter ac-
tivities include the histoneH3 lysine 4 (H3K4)methyltransferases
SETD1A and mixed lineage leukemia 1 (MLL), histone demethyl-
ases KDM1A and PHF8, histone acetyltransferase (HAT) KAT8,
histone deacetylase (HDAC) SIN3A, glycosyl transferase OGT,
ubiquitin hydrolase RNF2 (BAP-1), and the phosphatase PPA1
(for references, see Zargar and Tyagi 2012). Both these DNA-
binding transcription factors and chromatin-modifying activities
can be associated with either or both activation and repression of
transcription.
The aforementioned indicates that human HCFC1 could play
intimate and complex roles in the regulation of gene transcription,
andyet to date, a visionof the roles ofHCFC1at specific sites genome-
widehas been limited to a studyofHCFC1with themouse embryonal
stem (ES)–cell proliferation factor THAP11 (also known as Ronin)
(Dejosez et al. 2010). Here, we have examined HCFC1-genome
association through high-throughput chromatin immunoprecip-
itation (ChIP-seq) analysis of proliferating human HeLa cells. The
results show that HCFC1 can associate with the large majority of
active promoters in cells.
Results
HCFC1 is a major promoter-binding factor
To identify genomic sites bound byHCFC1, we performedChIP-seq
with asynchronously cycling HeLa cells using either HCFC1C- or
HCFC1N-subunit-specific antibodies. Figure 1A shows a represen-
tative selection of peaks from HCFC1C and HCFC1N ChIP-seq
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analyses in an annotated 500-kb region of thehumanXchromosome.
In this display, HCFC1 appears to be associated with the 59-proximal
regions of some but not all genes. Genome-wide analysis identified
8097 peaks in the HCFC1C ChIP-seq
peaks that can be categorized with re-
spect to transcription units as shown
inFigure 1BandTable 1 (for details, see
Methods and Supplemental Tables 1
and 2); the large majority of HCFC1C-
binding sites are within or near the
22,048 RefSeq-annotated transcrip-
tion units (83%), and fully 67% (5400)
are located near (1000 to +500 bp)
a transcription-start site (TSS). This
strong preference for HCFC1 binding
near TSSs can also be observed in
a cumulative plot of all HCFC1 peaks
(Fig. 1C). Of the 17% of HCFC1C-
binding sites located far from tran-
scription units (‘‘Intergenic’’ in Fig. 1B),
many are also likely to be associated
with transcription units (Table 1).
The large number of HCFC1C-binding
sites is consistent with HCFC1 being
an abundant chromatin-associated
factor (Wysocka et al. 2001); its pres-
ence nearmany TSSs (at least 5400 out
of 22,048, or a quarter) suggests the
potential for a broad role in transcrip-
tional regulation.
Because HCFC1 is a heterodimer
of HCFC1N and HCFC1C subunits, we
also performed ChIP-seq analysis for
the HCFC1N subunit. This analysis
revealed a similar number of HCFC1N
(8235) and HCFC1C (8097) binding
sites (Table 1), but they did not always
correspond to one another (Fig. 1A). A
supplementary quantitative PCR anal-
ysis of selected HCFC1N- and HCFC1C-
binding sites (Supplemental Fig. 2)
revealed that TSS-associated binding
sites identified in just one of the two
ChIP-seq analyses are, in fact, occupied
by both subunits. In contrast, a parallel
analysis of intergenic binding sites
indicated that only those appearing
in both ChIP-seq analyses are true
binding sites (Supplemental Fig. 2D).
These results suggest that HCFC1 as-
sociateswith chromatin as anHCFC1N–
HCFC1C heterodimer, consistent with
the recent finding that the two HCFC1
subunits associate via the formation
of a stable hybrid Fibronectin type
III–repeat structure (Park et al. 2012).
Consistent with this hypothesis, cu-
mulative mapping of HCFC1 subunit
binding sites (Fig. 1E) indicates that
on average both subunits bind 40 bp
upstream of the TSS.
Because the HCFC1C analysis ap-
peared more robust and the HCFC1N analysis revealed few addi-
tional HCFC1-binding sites (347 or 6%) (Fig. 1D), we chose to refer
to the HCFC1C analysis for the studies described below.
Figure 1. Genomic localization of human HCFC1. (A) Typical profile of HCFC1 peaks throughout the genome
(UCSCGenome Browser) andmagnification of one HCFC1 peak. Both HCFC1C andHCFC1N data are shown. (B)
Distribution of the HCFC1C peaks according to their genomic localization. (59 DIST) 5000 to 1000 of TSSs;
(TSS-PROX)1000 to +500 of TSSs; (39 PROX)500 to +1000 of end of transcript; (39 DIST) +1000 to +5000 of
end of transcript; exon and intron within the coding sequence only; (Intergenic) >5000 bp distal of annotated
transcript regions. Percentages of the total number of peaks are indicated for the TSS-PROX and intergenic re-
gions. (C ) Enrichment of HCFC1 peaks within and surrounding annotated transcript regions. All transcribed
regions are normalized to 10,000 bp. (D) Venn diagram showing the number of shared and distinct RefSeq TSSs
bound by either HCFC1C or HCFC1N. (E) Cumulative mapping of HCFC1N (blue), HCFC1C (black), Pol II (RPB2;
red), and H3K4Me3 (green) binding sites within250 to +250 of TSSs. Binding sites weremapped as the center
of ChIP-seq fragments artificially extended to the experimentally determined average fragment length. (Left axis)
Corresponds to HCFC1N, HCFC1C, and Pol II distribution; (right axis) corresponds to H3K4Me3 distribution. The
most enriched position for HCFC1C is indicated as the base pair distance from the TSS and by the dashed black
vertical line. TSS is indicated by the dashed gray vertical line.
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The presence of HCFC1 at TSSs correlates with transcriptional
activity
Given the association of HCFC1 with a quarter of annotated TSSs
in proliferating HeLa cells, we asked whether HCFC1-bound and
-unbound TSSs might differ in associated transcriptional activity
(Fig. 2). We thus performed ChIP-seq analyses for trimethylated
H3K4 (H3K4Me3) and TSS-associated RNA polymerase II (Pol II),
markers for active promoters, and trimethylatedH3K36 (H3K36Me3),
a marker for gene transcription (Bannister et al. 2005). Figure 2A
shows that HCFC1N- and HCFC1C-subunit binding is highly cor-
related with the H3K4Me3 and Pol II active promoter marks. Cu-
mulative mapping shows that the two HCFC1 subunits are gen-
erally positioned just upstream of the Rpb2 Pol II subunit and in
between H3K4Me3-modified histones (Fig. 1E).
To investigate further the relationshipofHCFC1TSS association
and transcriptional activity, we divided the 22,048 RefSeq-annotated
TSSs into four different groups (absent, low, medium, and high
HCFC1occupancy) according to the density ofHCFC1 sequence tags
over the250- to +250-bp TSS region. Figure 2B (panel a) shows the
distribution of HCFC1-binding densities of the TSS regions for each
selected group. In parallel, we plotted for the same four TSS groups
the corresponding (1) TSS-associated Pol II (panel b) and H3K4Me3
(panel c) density distributions, and (2) transcription unit–associated
H3K36Me3 (panel d) density distribution. Comparison shows an
excellent correlation between HCFC1 and Pol II, H3K4Me3, and
H3K36Me3 occupancy, suggesting that HCFC1 TSS presence corre-
lates with transcriptional activity. Consistent with this hypothesis,
HCFC1TSS occupancy also correlates withmRNA transcript levels as
determined by Affymetrix microarray analysis (Fig. 2B, panel e),
a measure, albeit indirect, of transcriptional activity.
Depletion of HCFC1 results in changes in mRNA level
for a large number of genes
Given the association of HCFC1 with active promoters, we asked
whether genes are generally misregulated in the absence of HCFC1.
We compared in triplicate, mRNA levels in cells treated with siRNA
against either HCFC1 or, as a negative control, luciferase (Supple-
mental Fig. 3A). We observed that for 19% of the transcription units
analyzed, the relative level of mRNA changed either up or down—
with a multiple testing corrected P-value of #0.05—upon depletion
ofHCFC1. This large number of changes inmRNA level uponHCFC1
depletion suggests a broad role for HCFC1 in the regulation of gene
transcription. Consistent with this conclusion, although the genes
affected differ, a broad effect on gene expression has also been ob-
served using another strategy of HCFC1 inactivation called cyto-
plasmic sequestration (Khurana and Kristie 2004).
For up-regulated genes (i.e., associated with HCFC1 repression),
HCFC1-bound and -unbound TSSs revealed little difference in the
number of genes affected (Fig. 3, bars 1 and 2) or in the level of re-
sponse (Supplemental Fig. 3B, plots 1 and 3). For down-regulated
genes (i.e., associated with HCFC1 activation), however, there was
a large difference (7% vs. 16%) in the number (Fig. 3, bars 3 and 4) as
well as in the level of response (Supplemental Fig. 3B, plots 2 and 4)
between HCFC1-unbound and -bound TSSs. These observations
suggest that HCFC1 directly and indirectly regulates gene transcrip-
tion with more often a direct role in transcriptional activation.
Indeed, the 74% of HCFC1-bound genes for which we do not
detect a change in gene expressionupondepletion ofHCFC1 could
in some cases represent genes that are regulated by HCFC1 at a
particular stage of the cell cycle and whose differential expression
might therefore be missed in an analysis of a heterogeneous pop-
ulation of asynchronized cells. To test this hypothesis, we syn-
chronized cells in S phase following a double-thymidine block
and performed both ChIP-seq of the HCFC1C subunit and com-
parative gene-expressionmicroarray analysis of HCFC1-depleted
and nondepleted cells. The large majority (89%) of the HCFC1-
bound TSSs that are associated with genes showing no expression
difference upon HCFC1 depletion in asynchronized cells are still
HCFC1-bound in S phase—interestingly, while not differentially
expressed in asynchronized HCFC1-depleted cells, 264 (8%) of
these genes significantly differ in expression in S phase (Supple-
mental Table 3). Consistent with an HCFC1-specific role in the
regulation of gene transcription, the ChIP-seq analysis shows
that, among these 264 S-phase-specific genes, 188 (71%) show
a TSS-associated increase in HCFC1 occupancy as shown for two
examples in Supplemental Figure 5. These results indicate that
HCFC1 plays a broad role in cell-cycle-specific regulation of gene
transcription.
Potential regulatory pathways controlled by HCFC1
The HCFC1-depletion microarray gene-expression analysis pro-
vides a tool to identify HCFC1 controlled regulatory pathways by
Gene Ontology analysis (Supplemental Table 4). Such an analysis
revealed many genes involved in cellular metabolism, with genes
activated by HCFC1 being mostly involved in the ubiquitin cycle,
DNA replication, cell division, and spindle formation. Perturbation
of any one or all of these processes could play a role in the cell-cycle
Table 1. Location of HCFC1 peaks
Feature
HCFC1C ChIP-seq
peaks
% of total HCFC1C
ChIP-seq peaks
HCFC1N ChIP-seq
peaks
% of total HCFC1N
ChIP-seq peaks
HCFC1C peaks positive
for HCFC1N peaks
All features (total) 8097 100 8235 100
RefSeq transcription unita 6742 83 6315 77 3866
TSS PROX region of transcribed unit 5460 (5400b) 67 3666 (4153b) 45 3806c
Intergenica 1347 17 1920 23 288
Alternative transcription unita 618 (180d) 7.6 682 8.3 192
Small noncoding RNAs 39 0.5 22 0.3 7
Repeat elements 395 4.8 528 6.4 22
No feature 295 3.6 688 8.4 67
aSee Methods for details.
bNumber of TSS-RefSeq transcription units bound by the subunit.
cTwo HCFC1C peaks can correspond to the same HCFC1N peak.
dPeak number falling within TSS-PROX regions of these transcription units.
HCFC1: Common component of active promoters
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defects (G1/S arrest and M phase) observed in the absence of
HCFC1. The genes more likely to be direct targets of HCFC1 regu-
lation (i.e., both change expression and are bound byHCFC1) affect
broad processes such as gene expression and RNA processing. These
results are consistentwith a picture of HCFC1 as a broad regulator of
gene expression.
TSS-associated HCFC1-binding sites lie within CpG islands
Approximately two-thirds of the RefSeq transcription unit pro-
moters possess relatively high concentrations of the dinucleotide
sequenceCpG (Illingworth et al. 2010), referred to as ‘‘CpG islands.’’
Comparison of the list of HCFC1-associated TSSs with a list of ex-
Figure 2. HCFC1 peaks correlate with sites of active promoters. (A) UCSCGenome Browser shot showing a typical distribution of HCFC1C and HCFC1N
binding sites together with Pol II, and H3K4Me3 and H3K36Me3 modified histones. (B) TSS regions (250 to +250 bp from TSSs) were split into four
categories according to the density of sequence tags (number of tags centered to the fragment length as in Fig. 1E divided by the number of base pairs, i.e.,
500) for HCFC1C (panel a). (A) Absent (density = 0, 6270 transcription units); (L) low density (density > 0 and #0.004, 4806 transcription units); (M)
medium density (density > 0.004 and #0.03, 7902 transcription units); (H) high density (density > 0.03, 3417 transcription units). The sequence-tag
densities for Pol II (panel b) and H3K4Me3 (panel c) at promoter regions and H3K36Me3 (panel d ) within transcribed regions are shown for each category.
The distribution of transcript abundance in log2 of transcripts in HeLa cells is shown for each category (panel e). The results are displayed as boxplots.
Michaud et al.
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perimentally defined human CpG-island promoters (Illingworth
et al. 2010) showed that there is a strong bias for HCFC1 association
with CpG-island promoters: 97% of TSS-associated HCFC1 peaks lie
within the CpG island of CpG-island promoters (Table 2). These
results suggest that there is a strong link between CpG island–con-
taining promoters and the recruitment of HCFC1.
CpG-island promoters are often more active than non-CpG-
island promoters (for review, see Antequera and Bird 1999). We
observe the same effect for the HeLa-cell mRNA analysis of Figure
2B (panel e), as shown in Figure 4 (cf. boxplots 1 and 2). Among the
genes with CpG-island promoters, those with promoters associ-
ated with HCFC1 are even more highly expressed (cf. boxplots 2
and 3 vs. 2 and 4), establishing association of HCFC1 with a large
number of active CpG-island promoters.
DNA sequence motifs corresponding to the human
transcription factors ZNF143, THAP11, GABP,
and YY1 are enriched in HCFC1-binding sites
Because HCFC1 is not known to bind directly to DNA but instead
to site-specific proteins that tether it to the DNA (see the intro-
duction), we searched for recurrent motifs in the DNA sequences
associated with the HCFC1 peaks to identify candidate proteins
that recruit HCFC1 to its target promoters. We searched for motifs
from 6 to 20 bp long within the 200-bp sequence (6100 bp) cen-
tered on each TSS-associated HCFC1C peak using the sequence-
analysis toolMEME (Bailey and Elkan 1994). This analysis revealed
threemotifs referred to as HCFC1MEMEMotifs 1 (20 bp long), 2 (9
bp), and 3 (12 bp) (Fig. 5A, panels a–c). All three motifs are highly
enriched in HCFC1-bound (15%–20%) versus HCFC1-unbound
(2%–3%) promoters (Fig. 5B) and are positioned within;10 bp of
theHCFC1 peak itself (Supplemental Fig. 4A), suggesting a binding
relationship between HCFC1 and the three HCFC1-associated
MEME motifs. In contrast, other motifs identified by the MEME
analysis were not enriched in HCFC1-bound promoters (see Sup-
plemental Fig. 4B).
The MEME analysis did not identify motifs for some tran-
scription factors known to associate with HCFC1, such as those for
E2F transcription factors (Knez et al. 2006; Tyagi et al. 2007). Direct
analysis revealed that the E2F1-binding-site motif is, indeed,
enriched in HCFC1-bound promoters, albeit less than the HCFC1
MEME Motifs 1–3. These results indicate that the HCFC1 MEME
Motifs 1–3 are likely the predominant HCFC1-associated motifs
but that more restricted HCFC1-binding-site-associated motifs are
also involved in HCFC1 function.
To identify DNA-binding transcription factor targets of
HCFC1, we compared the three MEME-motif sequences to motifs
for DNA-binding transcription factors in the TRANSFAC database
(Matys et al. 2006). The 39 half of HCFC1 MEME Motif 1 showed
strong similarity with the binding site for the human zinc-finger
transcription factor ZNF143 (also known as Staf). This motif also
matches a sequence identified in mouse embryonic stem (ES) cell
studies of binding sites for mouse HCFC1 and the DNA-binding
transcription factor THAP11 (Dejosez et al. 2010). HCFC1 MEME
Motifs 2 and 3 correlate with the binding sites for transcription
factors GABP and YY1 (Fig. 5A, panels b and c), respectively. In-
terestingly, of the four transcription factors associated with these
threemotif sequences, the human proteins GABP and YY1 and the
mouse protein THAP11 have been shown to bind HCFC1 (Vogel
and Kristie 2000; Dejosez et al. 2008; Yu et al. 2010). Although SP1
has been shown to associatewithHCFC1 (seeWysocka et al. 2003),
the SP1-binding site motif was not enriched at HCF-1-binding
sites. Although the reason is unclear, we note that the SP1-binding
site is frequent inCpGpromoters, whichmaymake an enrichment
more difficult to discern.
HCFC1 binds ZNF143
The fourth of the HCFC1 MEME motif–associated transcription
factors, human ZNF143, has been primarily characterized in the
context of regulation of RNU6 small nuclear RNA (snRNA) gene
transcription (Schaub et al. 1999; Yuan et al. 2007). HCFC1 was
previously found in a proteomic screen for ZNF143-associated
proteins, but the nature of the association was not defined (Yuan
et al. 2007). We therefore defined the association. In an extract
from cells containing an epitope-tagged HCFC1N subunit, epitope-
tag-specific immunoprecipitation recovered the endogenous ZNF143
protein (Fig. 6B). A pull-down experiment (Fig. 6C) with a purified
GST–ZNF143 fusion protein and HCFC1 fragments synthesized by
in vitro translation (Fig. 6A) showed that, in contrast to a control
GST–GFP protein (lanes 1,3), the GST–ZNF143 protein (lanes 2,4)
recovered all of the amino-terminal HCFC1N fragments but not the
HCFC1C subunit (cf. lanes 3 and 4). These results suggest that
ZNF143 binds the HCFC1 Kelch domain. Within ZNF143, the
DNA-binding domain (DBD) is sufficient to bind to the HCFC1
N380 Kelch domain (Fig. 6D). Thus, all four transcription factors
identified in the HCFC1 binding-site analysis bind HCFC1.
Nearly 90% of all HCFC1-bound promoters are also bound
by one or more of ZNF143, THAP11, GABP, or YY1
transcription factors
To examine the genomic relationship between HCFC1 and the four
human ZNF143, THAP11, GABP, or YY1 transcription factors, we
performed ChIP-seq analysis for each of these four DNA-binding
Figure 3. Effect of HCFC1 depletion on mRNA levels. Percentages of
HCFC1 unbound (1 and 3) or bound (2 and 4) TSSs that display a sig-
nificant differential expression upon depletion of HCFC1 for both the up-
regulated (1 and 2) and the down-regulated genes (3 and 4). The number
of TSSs used here is 20,571 because 7% of TSSs identified by ChIP-seq
analyses were not present on the Affymetrix chip.
Table 2. HCFC1 associates with CpG island promoters
Feature Total number
Number falling
within CpG islands Percentage
Human promoters 22,048 14,558 66%
HCFC1 peaks in
promoters
5747 5559 97%
HCFC1: Common component of active promoters
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transcription factors. GABP being an a/b heterodimer, we analyzed
the DNA-binding GABPA subunit. Of these four DNA-binding
transcription factors, three displayed, like HCFC1, a strong binding-
site bias for TSSs: Thus, 49% of the 3572 ZNF143-binding sites, 61%
of the 8042GABPA-binding sites, and 36%of the 7757 YY1-binding
sites identified were bound within 1000 to +500 bp of an anno-
tated TSS. In contrast, for THAP11, only 10% of the 8657 identified
binding sites were similarly associated with TSSs—40% were found
within transcription units. Only the THAP11 peaks associated with
TSSs, which possessed high scores, were analyzed here.
Our ChIP-seq analyses for each of these transcription factors
showed that the TRANSFAC motifs accurately predict binding by
these transcription factors with >90% of the identified motif se-
quences boundby the corresponding transcription factor in the case
of ZNF143, YY1, and GABP (Supplemental Fig. 4C). In contrast, we
observed more peaks than motif sequences, suggesting that these
transcription factors bind directly or indirectly other target motifs
as well.
We examined the coassociation of the four transcription
factors with HCFC1 at TSSs both in detail (Fig. 7A) and globally
(Fig. 5C). Figure 7A shows the gene-rich X-chromosome region
from the Immunoglobulin-binding protein 1 (IGBP1) to the OGT
gene together with peaks for HCFC1C, ZNF143, THAP11, GABPA,
andYY1. For comparison, CpG islands (Illingworth et al. 2010) and
the regions enriched for histone H3K36Me3-modified nucleo-
somes (i.e., transcriptionally active) are shown.
Figure 5. Identification of transcription factors associated with HCFC1-bound TSSs. (A) The HCFC1 MEME Motif logo identified in HCFC1-bound TSS-
associated sequences is displayed above themost similar TRANSFACmotif(s). For HCFC1MEMEMotif 1, themotif corresponding to the experimentally described
sequence for mouse Thap11 (Ronin) is also shown (Dejosez et al. 2010). (a) ZNF143 and THAP11; (b) GABP; (c) YY1. (B) Percentage of HCFC1-bound (+)
or -unbound () sequences that contain the HCFC1 MEME motif. (C ) Venn diagrams showing the overlap between HCFC1-bound TSS regions and
ZNF143, THAP11, GABPA, and YY1-bound TSS regions as identified by ChIP-seq. The percentages of TSS regions that contain the transcription factor-binding
sites and are HCFC1positive are given. (*) Percentage of ZNF143 binding sites that are HCFC1positive; (+) percentage of THAP11 binding sites that areHCFC1
positive. (D) Cumulative mapping of sequence tags around250 to +250 of TSSs (determined as in Fig. 1E) shared between HCFC1C and the corresponding
transcription factor. The most enriched position is indicated as the distance in base pairs from the TSS, which is indicated as a dashed vertical line.
Figure 4. HCFC1 and CpG island correlation. (A) Boxplot of the distri-
bution of the expression level in HeLa cells of genes lacking (1) or con-
taining (2) a CpG island (Illingworth et al. 2010) and genes containing
a CpG island with a peak for HCFC1 (3) or not (4).
Michaud et al.
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Seven, all TSS-associated, HCFC1C peaks (labeled 1–7) were
identified of which six are CpG-island associated and five associ-
ated with histone H3K36Me3 positive transcription units, consis-
tent with the aforementioned HCFC1 association with active
transcription units (see Fig. 2B). Interestingly, all seven HCFC1C-
bound TSSs are also associated with at least one of the four tran-
scription factors (Fig. 7, cf. A and B). This typical region illustrates
how the nature of specific transcription factors that colocalizewith
HCFC1 can be highly variable.
Genome-wide, 88%of the 5400HeLa-cell HCFC1-bound TSSs
are also bound by one or more of the four transcription factors
analyzed. Among the four transcription factors, we observed most
prominent coassociation on promoters between THAP11 and
ZNF143 (71% of THAP11 TSS-associated sites also display ZNF143
binding), consistent with the overlap between the ZNF143 and
THAP11DNA-binding-sitemotifs inHCFC1MEMEMotif 1 (Fig. 5A,
panel a), as well as the adjacent factor binding (see cumulative
mapping in Fig. 5D, panel a). Interestingly, whereas 71% of THAP11-
bound TSSs also display ZNF143 binding, only 37% (726 out of 1985)
of ZNF143-binding sites are associated with THAP11-binding sites.
A high percentage of the promoters bound by each of the four
DNA-binding transcription factors was also bound by HCFC1
(ZNF143, 91%; THAP11, 82%; GABPA, 74%; YY1, 76%) (Fig. 5C).
Furthermore, the colocalization of HCFC1 and these four DNA-
binding transcription factors on promoters revealed by the cumu-
lative mapping shown in Figure 5D suggests that they are often
associated with HCFC1 when bound to their target promoters. In
contrast, HCFC1 itself associates with sets of promoters that are
distinguished by a different DNA-binding protein(s) with which
it associates, creating distinct subsets of promoters depending on
the associated DNA-binding protein as shown in Figure 7. It seems
likely that this manner of HCFC1 association with promoters
permits it to regulate distinct groups of genes according to the
cellular context.
Discussion
For many years, the analysis of human transcriptional regulation
rested on the analysis of individual viral or cellular promoters (for
review, see Lemon and Tjian 2000). These studies accentuated the
specificity of transcriptional regulation because different pro-
moters often displayed dependence on different sets of site-specific
transcription factors. The availability of ChIP-seq allows a simul-
taneous genome-wide analysis of gene regulation, as presented
here. This analysis has accentuated a high degree of commonality
in the regulation of gene transcription. Thus, HCFC1, originally
discovered in a highly specific role in viral transcription, when
examined in proliferating humanHeLa cells is found to be broadly
associated with actively transcribed genes.
To date, few transcriptional ‘‘coregulators’’ that, like HCFC1,
associate directlywith sequence-specificDNA-binding transcription
factors but are not known to bind to DNA directly themselves, have
been analyzed for genome-wide occupancy. One, p300, does not
display the TSS specificity of HCFC1, because it is often associated
with enhancers as well as promoters (Visel et al. 2009; Ramos et al.
2010). In addition to showing TSS specificity, HCFC1 also displays
a high degree of specificity for CpG-island promoters. This may re-
flect the association of HCFC1 with chromatin-modifying activities
that can directly recognize the CpG dinucleotide (see below).
Although HCFC1 lacks known DNA-binding activity, the se-
quences underlying HCFC1 TSS-binding sites revealed sequence
motifs for the binding of ZNF143 and THAP11 together, and GABP
and YY1 individually. Interestingly, these four factors have all been
associated with cell proliferation, consistent with the role of HCFC1
in cell-cycle progression. For example, GABP regulates S-phase entry
(Yang et al. 2007), and inmice, THAP11 sustains ES-cell proliferation
(Dejosez et al. 2008).
ZNF143 and THAP11 have been previously characterized in-
dependently. InHeLa cells, ZNF143 regulates both noncoding small
RNA and protein-encoding gene transcription units (Anno et al.
2011). ZNF143 and mouse THAP11 both possess transcriptional
regulatory roles in mouse ES cells: ZNF143 regulates Nanog gene
expression (Chen et al. 2008), whichmaintains the undifferentiated
status of ES cells, and THAP11 maintains ES-cell proliferation
(Dejosez et al. 2008) and is often associated with HCFC1 on ES-cell
promoters (Dejosez et al. 2010). Shownhere, these two transcription
factors often co-occupy promoters, and of these co-occupied pro-
moters, 98% also bind HCFC1 (see Fig. 5), perhaps because both
ZNF143 and THAP11 can bind HCFC1 independently. These results
suggest that HCFC1, ZNF143, and THAP11 often partner to regulate
gene expression in different cell types including ES and cancer cells.
HCFC1: A frequent link between DNA-binding transcription
factors and chromatin modifiers
The studies presented here reveal that HCFC1 is a common com-
ponent of the transcriptional machinery found at active promoters
in proliferating human cells. Figure 8 showshowwe imagineHCFC1
playing a role at these promoters: HCFC1 associates at transcrip-
Figure 6. HCFC1 binds ZNF143. (A) Schematic representation of the
HCFC1 and ZNF143 proteins and fragments used in the analysis. Features
are indicated above the proteins, and HCFC1 fragment names are in-
dicated below. (B) Immunoprecipitation (IP) of extracts from control (lane
3) or Flag-HA–HCFC1N1011 positive cells (lanes 1,2) using Flag (lanes 2,3)
or a naive (TBP) antibody (lane 1). The proteins were immunoblotted
(WB) using HA or ZNF143 antibodies. (C ) GST-pull-down assay using ei-
ther GFP as negative control (lanes 1,3) or ZNF143 recombinant protein
(lanes 2,4) and different in vitro–translated full-length or fragments of
HCFC1 as indicated to the left. (D) GST-pull-down assay using different
fragments of ZNF143 (full-length [lanes 1,4]; DNA-binding domain [lanes
2,5]) or GFP (lanes 3,6 ), and the Kelch domain (N380) of HCFC1. (Su-
pernatant) Unbound material after pull-down; (pull-down) material re-
covered on the glutathione-agarose beads.
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tionally active TSSs with both sequence-specific DNA-binding tran-
scription factors (TFs) and a chromatin-modifying activity, of which
HCFC1 interacts with many (see the introduction); here we show
HCFC1 with an H3K4 histone methyltransferase (H3K4 HMT) as
histone H3K4 methylation is associated with active promoters.
Consistent with this model, (1) HCFC1 can bind many differ-
ent DNA-bound transcription factors often via the short and de-
generate D/EHxY HBM sequence; (2) HCFC1 associates with both
the MLL and SETD1A H3K4 histone methyltransferases on human
promoters (Tyagi et al. 2007); and (3) HCFC1-bound promoters are
highly H3K4 methylated (see Fig. 2), which forms binding sites for
components of the histone H3K4 methyltransferases (i.e., WDR5)
(Wysocka et al. 2005). In addition to these transcription factor
characteristics, nearly all promoter-boundHCFC1 is associated with
CpG islands. We note with interest that a component of H3K4
histonemethyltransferases—the CXXC domain of theMLL protein
(Allen et al. 2006) and the CXXC finger protein 1 component of the
SETD1A H3K4 histone methyltransferase (Lee and Skalnik 2005)
(shown in green)—binds to the unmethylated CpG dinucleotides
associated with active promoters.
The model illustrates the multiplicity of contacts via which
HCFC1 can associate—indirectly—withmany active promoters.We
imagine HCFC1 association with promoters being dynamic and
thus, for example, initiated andmaintained by differentmechanisms
(e.g., association with DNA-binding transcription factors to initiate
promoter association and with histone methyltransferases and CpG
Figure 7. Correlation between HCFC1 and transcription-factor binding patterns. (A) Genome distribution of peaks for HCFC1C and ZNF143, THAP11,
GABP, and YY1 transcription factors. CpG islands (Illingworth et al. 2010) are indicated. Actively transcribed transcription units are indicated using the
H3K36Me3 distribution. Genes bound by HCFC1 and actively transcribed are indicated at the bottom of the figure along with their direction of tran-
scription. (B) Summary of the distribution of the transcription-factor binding sites, CpG islands, and H3K36Me3 status for HCFC1-bound TSSs. The global
percentage of HCFC1C-bound TSSs containing each of the described features is indicated at the bottom.
Figure 8. Schematic representation of an HCFC1-containing transcrip-
tion initiation complex accentuating the multiple potential HCFC1 contact
points at an active CpG-island promoter in human cells (see text for details).
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DNA sequences to maintain promoter association). Whichever the
case, a multiplicity of interaction points for HCFC1 on the large
number of cellular promoters described here likely provides a rich
source of targets to regulate human gene transcription.
Methods
Cell culture
HeLa-S cells were grown in suspension in Joklik’s modified Eagle’s
medium ( JMEM) with 5% of fetal calf serum. Adherent HeLa cells
were grown in Dulbecco’s modified Eagle’s medium (DMEM) with
10% of fetal bovine serum. HeLa-S cells were synchronized as de-
scribed (Tyagi et al. 2007).
Chromatin immunoprecipitation (ChIP)
HeLa-S cells were cross-linked for 8 min using 1% formaldehyde.
DNA was isolated and sonicated to 100–300 bp using a Bioruptor
(Bioruptor UCD-200; Diagenode) and 30-sec pulses on and off
at maximum power. Sonicated DNA was immunoprecipitated,
washed, and eluted as described (Tyagi et al. 2007). Two 3 107 to
8 3 107 cells were used per ChIP-seq. The following antibodies
were used: polyclonal anti-HCFC1C (H12) (Wilson et al. 1993),
polyclonal anti-HCFC1N (961-1011) (Machida et al. 2009), poly-
clonal anti-Pol II (POLR2B, sc-67318), polyclonal H3K4Me3 (Abcam
ab-8580), polyclonal H3K36Me3 (Abcam ab-9050), polyclonal anti-
ZNF143 (Yuan et al. 2007), polyclonal anti-GABPA (sc-22810),
polyclonal anti-YY1 (sc-1703), and polyclonal anti-THAP11 (G4275)
(Dejosez et al. 2008).
Ultra-high-throughput sequencing and analysis
Five to 10 ng of ChIP-DNAwas transformed into libraries using the
ChIP-seq DNA Sample Prep Kit (Illumina) and sequenced on an
IlluminaGenomeAnalyzer 2. Total inputDNAwas also sequenced.
Thirty-eight-base-pair sequence tags were then aligned to the ge-
nome (NCBI36/hg18) using Eland and fetchGWI (Iseli et al. 2007).
All tags, regardless of the sequencing score, were used formapping.
Only the sequence tags with a unique and perfect match were
retained. Moreover, to reduce some potential PCR artifacts, a maxi-
mum of two identical sequence tags was kept for further peak
identification. Peak identification was performed using SISSRs
( Jothi et al. 2008)with theprogram’s default options (FDR= 0.001 as
compared to a random background model based on Poisson prob-
abilities), except for the following ones: The fragment length of the
library was as determined experimentally before the sequence
analysis; overlapping peaks were clustered together. The relatively
few peaks (5% on average) common between Input and ChIP
samples were excluded from subsequent analysis.
Transcription unit annotation
The standard list of protein-encoding genes used in this study was
generated from the UCSC Browser gene list filtered using their
RefSeq status (NM_ accession numbers for transcripts; priority to
validated status, release 37). Alternative 59 TSSs were kept as dis-
tinct transcripts. The transcripts with the longest 39 endswere used
if the TSSs were similar. If no validated RefSeq was available, pro-
visional RefSeq annotations were also used. Alternative lists were
generated with noncurated transcription units and other genomic
features. The peaks away from any RefSeq sequences (Intergenic)
were then compared with these alternative lists in the following
order: (1) small noncoding RNAs (from UCSC RNA Genes Table
and NR_ accession numbers from RefSeq), (2) Ensembl genes
(Hubbard et al. 2002), (3) SIB predicted genes, and (4) repeats.
Quantitative PCR
Quantitative PCR on ChIP samples was performed in duplicate
using MESA Blue qPCR Mastermix Plus for SYBR Assay from
Eurogentec and a Rotorgene RG300A sequence detector (Corbett
Research). The ChIP samples were normalized with the total Input
DNA amount using the DCt method.
Gene expression microarrays
Cells were treated with siRNA against HCFC1 or luciferase, as pre-
viously described ( Julien and Herr 2003), twice 12 h apart using
Oligofectamine (Invitrogen). RNA samples were collected 48 h
following the first transfection, labeled using the MessageAmp
II-Biotin Enhanced kit (Ambion 1791), and hybridized to the
GeneChip Human Genome U133 Plus 2.0 Array. Three biological
replicates were used for each condition. The analysis was done
using the R statistical software; the intensities of each probeset
were normalized and summarized using the Robust Multi-array
Analysis algorithm (RMA) (Irizarry et al. 2003), and differential
expression was assessed using the LIMMA package (Smyth 2004).
MEME motif search
One hundred base pairs on each side of the center of HCFC1 peaks
was used for a de novo search for 6- to 20-bp motifs using the se-
quence-analysis tool MEME (Bailey and Elkan 1994) with a com-
bined P-value <0.01 as threshold. The matrices generated byMEME
were then compared with the TRANSFAC database using the DNA-
binding motif similarity tool STAMP (Mahony and Benos 2007).
The MEMEmotifs were used to search in other sequence files using
the motif alignment and search tool MAST (Bailey and Gribskov
1998).
Coimmunoprecipitation
Nuclear extracts of Hela Flp-In cells (Tighe et al. 2004) or stable
HeLa Flp-In cells synthesizing a Flag- and HA-tagged HCFC1
N1011 fragmentwere prepared as described (Tyagi et al. 2007). The
extracts were precleared and then incubated overnight with anti-
Flag beads (M2, Sigma-Aldrich a-2220) or with TBP antibody (SL30)
(Ruppert et al. 1996) and mixed protein-Sepharose A/G (GE Health-
care). Immunoprecipitated material was immunoblotted using the
monoclonal anti-HA (12CA5) or polyclonal anti-ZNF143 (Yuan et al.
2007) antibodies.
Recombinant proteins and GST-pull-down assays
The GST-ZNF143 and GST-ZNF143/DBD (amino acids 220–428)
proteins were synthesized in bacteria as described (Yuan et al. 2007).
Sequences encoding GFP were cloned in the T7 expression system
from a pSBet (Schenk et al. 1995) vector containing a 59-GST tag
and synthesized in bacteria as for ZNF143. In vitro transcription/
translation and [35S]methionine labeling of HCFC1 fragments were
performed using the TNT T7Quick transcription/translation system
(Promega) as recommended by themanufacturer. Equal amounts of
recombinant GST fusion proteins were incubated overnight with
glutathione-agarose beads (Sigma-AldrichG4510) and the indicated
HCFC1 fragment.
Data access
Gene expression and sequencing data have been deposited in the
NCBIGene ExpressionOmnibus (GEO) (http://www.ncbi.nlm.nih.
gov/geo/) under accession number GSE31419.
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